Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 53674 | 1.945 |
09:34 ET | 107986 | 1.9944 |
09:36 ET | 85221 | 1.9807 |
09:38 ET | 34521 | 1.975 |
09:39 ET | 105146 | 1.975 |
09:41 ET | 22354 | 1.955 |
09:43 ET | 36409 | 1.9407 |
09:45 ET | 55543 | 1.9395 |
09:48 ET | 6987 | 1.92 |
09:50 ET | 15754 | 1.9201 |
09:52 ET | 70431 | 1.9194 |
09:54 ET | 6412 | 1.91 |
09:56 ET | 42330 | 1.9434 |
09:57 ET | 6765 | 1.925 |
09:59 ET | 27760 | 1.929 |
10:01 ET | 27246 | 1.925 |
10:03 ET | 4488 | 1.9293 |
10:06 ET | 126044 | 1.94 |
10:08 ET | 145694 | 1.9807 |
10:10 ET | 45339 | 1.975 |
10:12 ET | 22468 | 1.975 |
10:14 ET | 12347 | 1.9703 |
10:15 ET | 16809 | 1.97 |
10:17 ET | 93935 | 2 |
10:19 ET | 39900 | 1.9784 |
10:21 ET | 24202 | 1.995 |
10:24 ET | 48058 | 1.985 |
10:26 ET | 13123 | 1.975 |
10:28 ET | 8311 | 1.9707 |
10:30 ET | 1072 | 1.9707 |
10:32 ET | 17590 | 1.9899 |
10:33 ET | 3448 | 1.985 |
10:35 ET | 6667 | 1.99 |
10:37 ET | 22052 | 1.975 |
10:39 ET | 10676 | 1.9707 |
10:42 ET | 7177 | 1.975 |
10:44 ET | 1900 | 1.97 |
10:46 ET | 28950 | 1.985 |
10:48 ET | 68763 | 1.98 |
10:50 ET | 10779 | 1.98 |
10:51 ET | 31871 | 1.98 |
10:53 ET | 5443 | 1.99 |
10:55 ET | 1240 | 1.98 |
10:57 ET | 21784 | 1.98 |
11:00 ET | 10378 | 1.98 |
11:02 ET | 1271 | 1.975 |
11:04 ET | 18146 | 1.965 |
11:06 ET | 51036 | 1.99 |
11:08 ET | 38267 | 1.985 |
11:09 ET | 11530 | 1.995 |
11:11 ET | 54709 | 1.99 |
11:13 ET | 31422 | 2 |
11:15 ET | 6056 | 2 |
11:18 ET | 29564 | 1.9993 |
11:20 ET | 25373 | 1.995 |
11:22 ET | 7790 | 1.995 |
11:24 ET | 6822 | 1.995 |
11:26 ET | 1200 | 1.99 |
11:27 ET | 5330 | 1.994 |
11:29 ET | 14200 | 1.995 |
11:31 ET | 32652 | 1.9901 |
11:33 ET | 7945 | 2 |
11:36 ET | 5725 | 2 |
11:38 ET | 6911 | 1.995 |
11:40 ET | 2320 | 1.995 |
11:42 ET | 600 | 1.995 |
11:44 ET | 8308 | 1.9948 |
11:45 ET | 2600 | 2 |
11:47 ET | 1325 | 1.9999 |
11:49 ET | 22172 | 2 |
11:51 ET | 11258 | 1.9925 |
11:54 ET | 6100 | 2 |
11:56 ET | 8736 | 1.995 |
11:58 ET | 2547 | 1.995 |
12:00 ET | 21478 | 1.995 |
12:02 ET | 12534 | 1.995 |
12:03 ET | 10370 | 1.9901 |
12:05 ET | 25126 | 1.99 |
12:07 ET | 16522 | 1.99 |
12:09 ET | 385239 | 2.0025 |
12:12 ET | 105228 | 1.985 |
12:14 ET | 1347 | 1.9882 |
12:16 ET | 65731 | 1.97 |
12:18 ET | 110118 | 1.945 |
12:20 ET | 28489 | 1.9399 |
12:21 ET | 4294 | 1.94 |
12:23 ET | 1700 | 1.9338 |
12:25 ET | 7442 | 1.925 |
12:27 ET | 51815 | 1.92 |
12:30 ET | 1530 | 1.92 |
12:32 ET | 2126 | 1.9287 |
12:34 ET | 48258 | 1.91 |
12:36 ET | 4062 | 1.92 |
12:38 ET | 32281 | 1.915 |
12:39 ET | 22767 | 1.9001 |
12:41 ET | 5245 | 1.915 |
12:43 ET | 2098 | 1.91 |
12:45 ET | 1853 | 1.9163 |
12:48 ET | 3723 | 1.92 |
12:50 ET | 6175 | 1.9299 |
12:52 ET | 8341 | 1.935 |
12:54 ET | 9102 | 1.9205 |
12:56 ET | 10510 | 1.91 |
12:57 ET | 2206 | 1.915 |
12:59 ET | 53755 | 1.915 |
01:01 ET | 3234 | 1.925 |
01:03 ET | 13431 | 1.92 |
01:06 ET | 100 | 1.91 |
01:08 ET | 4350 | 1.9103 |
01:10 ET | 17442 | 1.92 |
01:12 ET | 11767 | 1.9154 |
01:14 ET | 500 | 1.91 |
01:15 ET | 36231 | 1.895 |
01:17 ET | 39470 | 1.88 |
01:19 ET | 22642 | 1.89 |
01:21 ET | 39495 | 1.885 |
01:24 ET | 2650 | 1.8877 |
01:26 ET | 68684 | 1.875 |
01:28 ET | 5061 | 1.88 |
01:30 ET | 8529 | 1.885 |
01:32 ET | 39430 | 1.92 |
01:33 ET | 4529 | 1.908 |
01:35 ET | 900 | 1.9001 |
01:37 ET | 3772 | 1.91 |
01:39 ET | 30156 | 1.92 |
01:42 ET | 4828 | 1.915 |
01:44 ET | 7520 | 1.9199 |
01:46 ET | 1045 | 1.915 |
01:48 ET | 19409 | 1.905 |
01:50 ET | 3252 | 1.9 |
01:51 ET | 18268 | 1.905 |
01:53 ET | 2276 | 1.905 |
01:55 ET | 600 | 1.905 |
01:57 ET | 1417 | 1.9007 |
02:00 ET | 900 | 1.905 |
02:02 ET | 5228 | 1.9117 |
02:04 ET | 100 | 1.915 |
02:06 ET | 2500 | 1.915 |
02:08 ET | 1100 | 1.915 |
02:11 ET | 957 | 1.915 |
02:13 ET | 26279 | 1.92 |
02:15 ET | 800 | 1.92 |
02:18 ET | 11992 | 1.9184 |
02:20 ET | 8942 | 1.905 |
02:22 ET | 200 | 1.905 |
02:24 ET | 18739 | 1.89 |
02:26 ET | 400 | 1.8907 |
02:27 ET | 100 | 1.895 |
02:29 ET | 4932 | 1.905 |
02:31 ET | 6221 | 1.9009 |
02:33 ET | 8825 | 1.895 |
02:36 ET | 200 | 1.89 |
02:38 ET | 2261 | 1.895 |
02:40 ET | 3346 | 1.89 |
02:42 ET | 776 | 1.8907 |
02:44 ET | 12638 | 1.8992 |
02:45 ET | 2323 | 1.89 |
02:47 ET | 1245 | 1.895 |
02:49 ET | 10918 | 1.9 |
02:51 ET | 4335 | 1.905 |
02:54 ET | 5235 | 1.905 |
02:56 ET | 800 | 1.9 |
02:58 ET | 2424 | 1.9 |
03:00 ET | 15602 | 1.89 |
03:02 ET | 1722 | 1.8993 |
03:03 ET | 4300 | 1.9 |
03:05 ET | 1500 | 1.8999 |
03:07 ET | 15760 | 1.9 |
03:09 ET | 1736 | 1.9 |
03:12 ET | 18133 | 1.905 |
03:14 ET | 14696 | 1.915 |
03:16 ET | 13612 | 1.905 |
03:18 ET | 3374 | 1.905 |
03:20 ET | 2000 | 1.9089 |
03:21 ET | 800 | 1.905 |
03:23 ET | 500 | 1.905 |
03:25 ET | 7000 | 1.9 |
03:27 ET | 1886 | 1.9 |
03:30 ET | 19085 | 1.91 |
03:32 ET | 1300 | 1.905 |
03:34 ET | 700 | 1.905 |
03:36 ET | 800 | 1.9 |
03:38 ET | 43760 | 1.915 |
03:39 ET | 33174 | 1.915 |
03:41 ET | 22282 | 1.925 |
03:43 ET | 20528 | 1.92 |
03:45 ET | 2613 | 1.93 |
03:48 ET | 7227 | 1.93 |
03:50 ET | 7951 | 1.9388 |
03:52 ET | 19530 | 1.95 |
03:54 ET | 26977 | 1.945 |
03:56 ET | 56754 | 1.945 |
03:57 ET | 8441 | 1.95 |
03:59 ET | 174898 | 1.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 147.3M | 9.8x | --- |
Spero Therapeutics Inc | 88.9M | 3.9x | --- |
2Seventy Bio Inc | 230.8M | -1.1x | --- |
Rigel Pharmaceuticals Inc | 172.3M | -8.4x | --- |
Seres Therapeutics Inc | 145.7M | -1.5x | --- |
Alimera Sciences Inc | 182.3M | -1.5x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $147.3M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.16 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 9.8x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | 7.9x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.